Resistance isn’t futile – how to tackle drug-resistant superbugs
Science news, comment and analysis | theguardian.com,
Low profit margins and the difficulty of finding new drugs has led to big pharma shutting down its antibiotics programmes. But…
Low profit margins and the difficulty of finding new drugs has led to big pharma shutting down its antibiotics programmes. But…
Low profit margins and the difficulty of finding new drugs has led to big pharma shutting down its antibiotics programmes. But…
(iStock) One of the ways humans combat invading pathogens – such as Staphylococcus aureus (“staph”) – is by hiding nutrients…